SpoiledChild and Il Makiage mum or dad firm Oddity Tech Ltd. is extending its data-driven product growth mannequin into OTC and non-prescription dermatological care with its current launch of METHODIQ, a telehealth platform that mixes AI-enabled pores and skin evaluation, clinician oversight and customised therapy plans.
CosmeticsDesign US spoke to Tom Amsterdam, CEO of METHODIQ, who defined that whereas the platform contains prescription choices, the identical efficacy-first framework applies to its OTC and beauty merchandise, that are developed to satisfy greater substantiation and efficiency expectations.
Efficacy driving formulation and ingredient requirements
Based on Amsterdam, shifting client expectations are pushing the private care sector towards extra rigorous growth benchmarks.
“Efficacy has turn out to be the forcing operate throughout magnificence, wellness, and healthcare,” Amsterdam mentioned. “Customers are now not glad with beauty guarantees alone – they count on merchandise to work, be measurable, and stand as much as medical-grade requirements.”
He added that the standard distinction between magnificence and healthcare is changing into much less related to finish customers. “Right this moment’s customers are now not separating magnificence and pores and skin issues from healthcare,” he defined. “Ingredient effectivity and formulation requirements are being pulled in direction of correct medical benchmarks somewhat than beauty guarantees alone.”
For suppliers and formulators, this shift is growing demand for components supported by stronger knowledge, clearer mechanisms of motion and measurable outcomes, even for non-prescription merchandise.
AI-enabled ingredient innovation past off-the-shelf actives
METHODIQ’s product growth technique additionally highlights how knowledge science and biotechnology are influencing ingredient innovation. The corporate is drawing on its in-house biotech capabilities at Oddity Labs to develop proprietary compounds to be used throughout its portfolio, together with OTC and beauty formulations.
“Within the first six months following launch, METHODIQ will introduce 4 hero merchandise powered by proprietary compounds developed by Oddity Labs,” Amsterdam mentioned. “This marks a deliberate shift from counting on current, off-the-shelf components to creating our personal breakthrough formulation.”
AI performs a central function on this strategy. “We use a proprietary, AI-driven molecular discovery engine to determine novel molecules with extremely focused efficacy,” he defined, which “permits us to develop differentiated, state-of-the-art remedies that immediately deal with customers’ most urgent wants.”
He added that the identical growth philosophy applies no matter product class, as “our portfolio spans prescription, OTC, and beauty merchandise, all unified by the identical efficacy-first philosophy.”
Scientific validation and knowledge transparency shaping R&D
Past ingredient discovery, AI-driven diagnostics and progress monitoring are influencing how merchandise are developed and validated. Amsterdam mentioned METHODIQ was designed as an built-in system somewhat than a standalone product providing.
“With 4 years of heavy R&D funding for METHODIQ, we’ve created an entire system to drive outcomes,” he mentioned. “Not only a single product resolution, however a full package deal with dermatologist-developed formulation, superior laptop imaginative and prescient for diagnostics and monitoring, customized protocols, and a cell app for steering and check-ins.”
For Oddity, this system-level strategy is dashing up growth timelines whereas elevating scientific expectations. “AI is accelerating every part from ingredient discovery to medical validation,” Amsterdam mentioned, including that data-driven suggestions loops enable for steady optimization of formulations and protocols.
Navigating beauty and drug regulatory boundaries
As curiosity grows in merchandise that sit between beauty and therapeutic positioning, Amsterdam confused the significance of regulatory self-discipline. “At Oddity, we’re very deliberate about respecting regulatory boundaries whereas nonetheless pushing innovation ahead,” he mentioned. “Each product is developed, positioned, and substantiated in line with the extra rigorous regulatory framework to which it belongs.”
He added that readability round claims is important for producers working on this area. “Our strategy begins with intent and claims,” Amsterdam defined. “If it’s beauty, we guarantee claims, components, and substantiation keep firmly inside that definition, even when the underlying science is superior.”
Provide chain alternatives in data-driven skincare platforms
Wanting forward, Amsterdam foresees AI, laptop imaginative and prescient and telehealth platforms as remodeling skincare into adaptive techniques somewhat than static regimens. “Collectively, these applied sciences transfer skincare towards higher efficacy with true personalization at scale,” he mentioned.
He famous that this evolution might reshape provider relationships. “For ingredient and formulation companions, the chance lies in working earlier and extra collaboratively inside this ecosystem,” Amsterdam defined, predicting that “the availability chain will more and more favor companions who can combine science, knowledge, and manufacturing excellence to help customized care with demonstrable outcomes.”
